Blog
19 September, 2023
Only 7.5% are carried out in health centres. In order to alleviate this situation, Farmaindustria has presented a programme to promote them in outpatient clinics. Source: […]
14 September, 2023
“We are going to create a favourable environment”. This statement by José Manuel Miñones is the first step towards a roadmap that would highlight the key […]
12 September, 2023
“We must take advantage of the opportunity provided by the Spanish Presidency of the Council of the EU to include health, medicines and the innovative pharmaceutical […]
25 July, 2023
Over the next five years, the number of cancer treatments consisting of more than one drug will double, with 68 authorisations expected to be granted The […]
18 July, 2023
The forum, organised by the Menéndez Pelayo International University (UIMP) and Farmaindustria, will be held on 7 and 8 September in Santander Patient representatives, drug authorities, […]
10 July, 2023
The sector invests 41.5 billion euros in research and directly employs some 840,000 people 300 billion, exports ¤565 billion and contributes ¤175 billion to the EU-27 […]
4 July, 2023
Last year, the sector contributed 313 million euros for organisations and healthcare professionals to participate in research and development activities for new treatments For the eighth […]
27 June, 2023
One out of every three tests carried out in Europe takes place in Spain. Investment has grown by 5.3% annually since 2011, to almost 800 million […]
19 June, 2023
The associate director of Clinical and Translational Research at Farmaindustria, Amelia Martín Uranga, explained at a forum organised by the POP that work is already underway […]
5 June, 2023
The director of Farmaindustria’s Access Department, Isabel Pineros, explains the situation of these drugs in Spain at a conference organised by the Kronos Foundation, the Hospital […]
30 May, 2023
On 23 May, part of the Distefar team attended the biomedical research technology platform. The opening was a conference by Juan José Vaquero, entitled “Strategy for […]
25 May, 2023
The director of Farmaindustria’s Access department analyses the challenges in the access of these patients to pharmaceutical innovation at a conference of the Spanish Society of […]
22 May, 2023
International Clinical Trials Day commemorates the importance of clinical trials every 20 May Clinical trials advance medicine and address unmet medical needs Source: farmaindustria.es In the […]
11 May, 2023
The Deputy Director General of Farmaindustria, Javier Urzay, recalls that this is a key moment to define the country’s strategy in research to face the new […]
8 May, 2023
This measure allows for greater participation and the inclusion of a more diverse population, which improves the scientific quality of the studies, as highlighted by Farmaindustria’s […]
2 May, 2023
In the opinion of the employers’ association, it “represents yet another barrier to patient access to innovative treatments” Source: espaciosanitario.com Following the proposed revision of the […]
24 April, 2023
Farmaindustria brings together in Spain the main European National Associations representing the innovative pharmaceutical industry and the European Federation of the Pharmaceutical Industry together with the […]
17 April, 2023
Farmaindustria states that it is “the first sectoral code approved by the AEPD and a reference at European level” Source: espaciosanitario.com Farmaindustria has announced that a […]
13 March, 2023
Source: elperiodico.com Multiple sclerosis is an autoimmune disease of the central nervous system that affects the brain and spinal cord. It is caused by damage to […]
8 March, 2023
Data from the Spanish Clinical Trials Register reveal the commitment of the pharmaceutical industry, which finances 88% of trials with paediatric patients. Incentives for innovation are […]
21 February, 2023
Oncology is one of the key issues on the health agenda that Spain will take to the Presidency of the Council of the European Union in […]
13 February, 2023
Farmaindustria’s Director of Access, Isabel Pineros, analyses the current challenges of access to therapeutic innovation at the Spanish Summit against Cancer, organised by Gepac “We must […]
6 February, 2023
Three times the number of three years ago Source: actasanitaria.com The health group HM Hospitales has reported that “almost 1,300” patients participated in 2022 in clinical […]
30 January, 2023
2021 closes with the best R&D investment figures ever: the pharmaceutical industry allocates 1,267 million euros to both private and public projects. Source: elespanol.com Investing in […]
23 January, 2023
The project is called Borders should no longer be barriers and has been promoted by Efpia and the European Good Clinical Practice Forum, in collaboration with […]
17 January, 2023
25% of the studies authorised last year are already for orphan drugs to combat rare diseases 86% of trials are driven by the pharmaceutical industry Javier […]
10 January, 2023
The pharmaceutical industry in Spain has a total of 103 production plants, a figure that rises to 173 when active ingredients and veterinary medicines are added […]
20 December, 2022
The figure reached in 2021 is 9% higher than in 2020, when, despite the pandemic, the sector achieved the second best record in its history up […]
13 December, 2022
A Dutch team has developed a cell therapy for metastatic melanoma that improves on the current standard. Source: elespanol.com Researchers in the Netherlands and Denmark have […]
12 December, 2022
Representatives of scientific societies, public administrations, researchers and pharmaceutical companies make up the group. Clinical research at this level of care has a great opportunity for […]
28 January, 2020
They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]